A new Lyme disease vaccine candidate is making headlines after showing more than 70% efficacy in a Phase 3 trial, offering a hopeful step forward in the fight against tick-borne illness.
Watch the news segments featuring Braman Termite & Pest Elimination Technical Director Natasha Wright for expert insight on what this news could mean and why tick prevention matters more than ever right now.